First-line agents for renoprotection are angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers at the higherst toleratedose. The combination of these types of drugs, the so-called dual blockade, further reduces an elevated urinary albumin or protein excretion but, at least in...